Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma (Hnscc): Post Hoc Analyses of Treatment Options from the Phase Iii Keynote-040 Trial

AuthID
P-00Q-93T
15
Author(s)
Le Tourneau, C
·
Harrington, KJ
·
Dinis, J
·
Licitra, L
·
Ahn, MJ
·
Soria, A
·
Machiels, JP
·
Mach, N
·
Mehra, R
·
Burtness, B
·
Zhang, P
·
Cheng, J
·
Swaby, R
·
Soulieres, D
Document Type
Abstract
Year published
2018
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 29
Conference
43Rd Esmo Congress (Esmo), Date: OCT 19-23, 2018, Location: Munich, GERMANY, Sponsors: European Soc Med Oncol, Japanese Soc Med Oncol
Indexing
Publication Identifiers
Wos: WOS:000459277302225
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.